Association of HOTAIR gene polymorphisms and biochemical markers to uterine fibroids in Egyptian women. Authors: Mona M. Gad, Hossam Abdel-Megeed Abdou, Magdy M. Youssef Published: 2026 ABSTRACT BackgroundUterine fibroids (UFs) are the most common benign tumors of the female reproductive system, with a multifactorial etiology involving genetic, hormonal, and inflammatory mechanisms. Long non-coding RNA HOX transcript antisense intergenic RNA (HOTAIR) has been implicated in tumorigenesis; however, the role of its genetic polymorphisms in uterine fibroids remains insufficiently explored.AimThis study aimed to investigate the association between HOTAIR gene polymorphisms (rs1899663, rs12826786, and rs4759314) and susceptibility to uterine fibroids in Egyptian women, as well as their relationship with inflammatory, hormonal, and biochemical parameters.MethodsA total of 200 participants were enrolled, including 100 uterine fibroid patients and 100 age-matched healthy controls. Genotyping of HOTAIR polymorphisms was performed using amplification refractory mutation system polymerase chain reaction (ARMS-PCR). Serum cytokines, hormonal markers, and biochemical parameters were measured using ELISA and standard clinical methods. Statistical analyses were conducted to evaluate genotype–phenotype associations and disease risk.ResultsThe rs12826786 polymorphism showed a significant association with uterine fibroid susceptibility, with the T allele being more frequent in patients than controls (45.5% vs. 33.5%, OR = 1.657, p = 0.019). Significant associations were also observed under the dominant and codominant genetic models (p = 0.026). In contrast, rs1899663 and rs4759314 polymorphisms showed no significant association. Uterine fibroid patients exhibited significantly elevated levels of inflammatory cytokines (IL-1β, IL-10, TNF-α, IFN-γ), hormonal markers (prolactin and estradiol), and liver enzymes (ALT, AST, ACP), along with decreased total protein and albumin levels (p < 0.001). A significant association between rs12826786 and ALT levels was also observed (p = 0.038). Principal component analysis demonstrated clustering patterns influenced by inflammatory and hormonal parameters.ConclusionThis study demonstrates that the HOTAIR rs12826786 polymorphism is significantly associated with increased susceptibility to uterine fibroids in Egyptian women, potentially through modulation of inflammatory and hormonal pathways. These findings highlight the potential role of lncRNA polymorphisms as biomarkers for uterine fibroid risk. However, further studies in larger and diverse populations are required to validate these findings. Introduction Uterine fibroids (UFs), also known as leiomyomas, are the most common benign tumors of the female reproductive system, affecting up to 70% of women of reproductive age worldwide.1 Despite their benign nature, UFs are associated with significant morbidity, including abnormal uterine bleeding, pelvic pain, infertility, and pregnancy complications, thereby representing a major public health burden.2 The pathogenesis of uterine fibroids is complex and multifactorial, involving the interplay of genetic, hormonal, environmental, and epigenetic factors.3, 4 Accumulating evidence suggests that chronic inflammation and cytokine dysregulation play a central role in the development and progression of uterine fibroids. Pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interleukins (IL-1β and IL-10), and interferon-γ (IFN-γ), contribute to fibrotic remodeling by promoting extracellular matrix deposition and cellular proliferation. These inflammatory pathways are closely linked to hormonal signaling, particularly estrogen and prolactin, which further stimulate fibroid growth and survival.5 In recent years, long non-coding RNAs (lncRNAs) have emerged as key regulators of gene expression and epigenetic modification in various physiological and pathological processes. Among them, HOX transcript antisense intergenic RNA (HOTAIR) is one of the most extensively studied lncRNAs, known for its role in chromatin remodeling and transcriptional regulation through interaction with polycomb repressive complex 2 (PRC2) and lysine-specific demethylase 1 (LSD1). Aberrant expression of HOTAIR has been implicated in tumorigenesis, fibrosis, and hormone-dependent diseases, suggesting its potential involvement in uterine fibroid development.6, 7 Genetic polymorphisms within lncRNA genes, including HOTAIR, may influence their expression and functional activity, thereby modulating individual susceptibility to disease. Several studies have reported associations between HOTAIR polymorphisms and various cancers8, 9, 10, 11, 12; however, data regarding their role in uterine fibroids remain limited and inconsistent, particularly across different ethnic populations.13 Understanding the genetic contribution of HOTAIR variants may provide new insights into the molecular mechanisms underlying fibroid pathogenesis. HOTAIR may play an important role in uterine fibroid pathogenesis through its epigenetic regulatory functions and its interaction with signaling pathways involved in cellular proliferation, apoptosis, extracellular matrix deposition, and hormonal responsiveness.13, 14 Through its interaction with Polycomb Repressive Complex 2 (PRC2) and lysine-specific demethylase 1 (LSD1), HOTAIR regulates chromatin organization and the transcription of genes involved in proliferative and fibrotic processes, thereby influencing cellular functions relevant to uterine fibroid development.14 The selected polymorphisms, rs1899663, rs12826786, and rs4759314, have previously been investigated in uterine leiomyoma and several proliferative or hormone-related disorders because of their potential regulatory relevance and reported associations with disease susceptibility.9, 15 As these polymorphisms are located within intronic or potentially regulatory regions of the HOTAIR gene, they may influence HOTAIR expression or regulatory activity and consequently contribute to individual susceptibility to uterine fibroids.15 However, the precise functional significance of these polymorphisms in the pathogenesis of uterine fibroids remains to be fully elucidated, and further functional and mechanistic studies are warranted to clarify their biological effects and potential clinical relevance.13, 14, 15In addition to genetic factors, alterations in biochemical and hormonal parameters have been increasingly recognized in UF patients. Elevated levels of inflammatory cytokines, liver enzymes, and hormonal markers reflect the systemic impact of fibroids and may serve as potential biomarkers for disease progression.16 Therefore, the present study aimed to investigate the association between HOTAIR gene polymorphisms (rs1899663, rs12826786, and rs4759314) and susceptibility to uterine fibroids in Egyptian women. Furthermore, we evaluated the relationship between these genetic variants and inflammatory, hormonal, and biochemical parameters, to provide a comprehensive understanding of the molecular and clinical features of uterine fibroids. Materials and methods This hospital-based case–control study was conducted at Mansoura University Hospitals, Egypt, and included a total of 200 participants comprising 100 women with ultrasonographically confirmed uterine fibroids (UF) and 100 age-matched healthy controls. The sample size was determined based on participant availability during the study period and was comparable to those reported in previous hospital-based case–control studies investigating the association of HOTAIR polymorphisms with uterine leiomyoma and other disease susceptibilities.11, 12, 15 Although no formal a priori sample size calculation was performed, the enrolled cohort was considered appropriate for an exploratory genetic association study aimed at evaluating the relationship between HOTAIR polymorphisms and uterine fibroid susceptibility in the Egyptian population. Cases were diagnosed by experienced gynecologists based on clinical evaluation and pelvic ultrasonography according to established clinical and imaging criteria for uterine leiomyoma.17, 18Control subjects were selected based on the absence of clinical symptoms, laboratory abnormalities, or imaging findings suggestive of uterine fibroids or other gynecological disorders. Participants were excluded if they were pregnant or lactating, receiving hormonal therapy, or had a history of malignancy, chronic liver disease, renal impairment, autoimmune disorders, hematological diseases, or viral hepatitis (HBV/HCV). Written informed consent was obtained from all participants prior to enrollment. The study protocol was approved by the Ethics Committee of the Faculty of Medicine, Mansoura University (Approval No. Sci-Ch-ph -2021-136; Date: 04/10/2021), and all procedures were conducted in accordance with the Declaration of Helsinki. Peripheral venous blood samples (5 mL) were collected from each participant under standardized conditions. Briefly, 3 mL of blood were collected into EDTA-containing tubes for genomic DNA extraction, while the remaining 2 mL were placed in plain tubes, allowed to clot, and centrifuged at 3000 rpm for 10 min to obtain serum. Serum samples were aliquoted and stored at −20 °C until analysis. Serum cytokines, hormonal, and biochemical parameters were quantified using validated laboratory methods. Serum interleukin-1 beta (IL-1β) and interleukin-10 (IL-10) concentrations were measured using commercially available sandwich enzyme-linked immunosorbent assay (ELISA) kits (Elabscience Biotechnology Co., Wuhan, China) according to the manufacturer's instructions. Serum tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) levels were determined using human ELISA kits (Cat. No. ELH-TNF-α and ELH-IFN-γ, respectively; China). Serum prolactin (PRL) levels were quantified using a prolactin ELISA kit (Cat. No. EK-310-37, Phoenix Pharmaceuticals, CA, USA), while estradiol (E2) levels were measured using an enzyme immunoassay kit (Cat. No. GWB-AFC6IF, GenWay Biotech, CA, USA). All ELISA procedures were performed in strict accordance with the manufacturers' protocols, and all samples and standards were analyzed in duplicate. Absorbance was measured at 450 nm using a BioTek ELx800 microplate reader (BioTek Instruments, USA). Biochemical parameters were assessed using established clinical chemistry methods. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were determined using kinetic methods according to the recommendations of the International Federation of Clinical Chemistry (IFCC), using commercially available diagnostic kits (Egyptian Company for Biotechnology, S.A.E., Egypt). Acid phosphatase (ACP) activity was measured using the α-naphthyl phosphate kinetic method (Bambolim Complex, India). Serum total protein was quantified using the biuret colorimetric method, and albumin levels were determined using the modified bromocresol green method. All biochemical analyses were performed using a calibrated UV–visible spectrophotometer, and internal quality controls were included in each analytical run to ensure accuracy and reproducibility. All laboratory measurements were conducted by trained personnel blinded to the clinical status and genotype of the participants to minimize potential bias. Given that a substantial proportion of participants were in the peri-menopausal age range (∼40 years), a period typically associated with reduced circulating estradiol levels, the relatively lower E2 concentrations observed in both UF patients and controls are considered physiologically consistent with age-related hormonal decline..9, 15 These single nucleotide polymorphisms (SNPs) are located within intronic or regulatory regions of the HOTAIR gene and have been proposed to influence HOTAIR expression or regulatory activity, making them biologically relevant candidates for investigating genetic susceptibility to uterine fibroids.13, 14 Genomic DNA was isolated from 200 μL of whole blood using the GeneJET Genomic DNA Purification Kit (Thermo Fisher Scientific, Lithuania; Cat. No. K0721), following the manufacturer's protocol. DNA concentration and purity were assessed using a NanoDrop spectrophotometer, and samples were stored at −20 °C until further analysis. Three single nucleotide polymorphisms (SNPs) in the HOTAIR gene (rs1899663, rs12826786, and rs4759314) were selected based on their reported association with tumor susceptibility and potential functional relevance. Genotyping was performed using the amplification refractory mutation system polymerase chain reaction (ARMS-PCR), which utilizes allele-specific primers Table 1.15 PCR amplification was carried out in a final reaction volume of 20 μL containing PCR master mix, allele-specific primers, genomic DNA template, and nuclease-free water. Thermal cycling conditions included an initial denaturation at 95 °C for 5 min, followed by 35 cycles of denaturation at 95 °C for 30 s, annealing at 55 °C for rs1899663, 62 °C for rs12826786, and 60 °C for rs4759314, and extension at 72 °C for 30 s, with a final extension at 72 °C for 5 min. PCR products were separated on 2–2.5% agarose gels, stained with ethidium bromide, and visualized under ultraviolet illumination. The expected fragment sizes were 126 bp, 364 bp, and 207 bp for rs1899663, rs12826786, and rs4759314, respectively. To ensure genotyping accuracy, a subset of samples was randomly selected and reanalyzed, yielding consistent results.Table 1ARMS-PCR primers used for genotyping HOTAIR polymorphisms.SNPPrimer sequenceSize (bp)rs1899663Forward C: AAAGCCTCTAATTGTTGTCATCForward A: AAAGCCTCTAATTGTTGTCATAReverse: AGACCCTCAGGTCCCTAATA126rs12826786Forward: AGACCTTGGTCCAATTCCCCReverse G: AGAGGGAAGGAGCTTAGGATAAACGReverse A: AGAGGGAAGGAGCTTAGGATAAACA364rs4759314Forward G: GGAAGGGATATAAACAGGCGAGForward A: GGAAGGGATATAAACAGGCGAAReverse: CAGGTACGCCTGAGTGTTCAC207 Table 1ARMS-PCR primers used for genotyping HOTAIR polymorphisms.SNPPrimer sequenceSize (bp)rs1899663Forward C: AAAGCCTCTAATTGTTGTCATCForward A: AAAGCCTCTAATTGTTGTCATAReverse: AGACCCTCAGGTCCCTAATA126rs12826786Forward: AGACCTTGGTCCAATTCCCCReverse G: AGAGGGAAGGAGCTTAGGATAAACGReverse A: AGAGGGAAGGAGCTTAGGATAAACA364rs4759314Forward G: GGAAGGGATATAAACAGGCGAGForward A: GGAAGGGATATAAACAGGCGAAReverse: CAGGTACGCCTGAGTGTTCAC207 ARMS-PCR primers used for genotyping HOTAIR polymorphisms. Principal component analysis (PCA) and correlation matrix analyse were performed to explore multivariate relationships among biochemical, hormonal, and inflammatory parameters. PCA was conducted using R software (version 4.x) with the prcomp function, and visualization was performed using factoextra and ggplot2 packages. All variables were standardized using z-score transformation prior to analysis, and PCA plots included 95% confidence ellipses to assess clustering patterns. Correlation matrices were generated using corrplot in R and seaborn in Python. Statistical analysis Statistical analyses were performed using GraphPad Prism version 10.1.1 (GraphPad Software Inc., San Diego, CA, USA) and R software. The distribution of continuous variables was assessed using the Kolmogorov–Smirnov test. Normally distributed data were expressed as mean ± standard error of the mean (SEM), while non-normally distributed variables were presented as median and interquartile range (IQR). Comparisons between UF patients and controls were performed using the unpaired Student's t-test or Mann–Whitney U test as appropriate. Differences across genotype groups were evaluated using one-way analysis of variance (ANOVA) or Kruskal–Wallis test followed by appropriate post hoc analyses. Genotype and allele frequencies were analyzed using the Chi-square test or Fisher's exact test. Hardy–Weinberg equilibrium (HWE) was assessed in the control group. The association between HOTAIR polymorphisms and uterine fibroid risk was estimated using odds ratios (ORs) with 95% confidence intervals (CIs) under different genetic models. A two-tailed p-value <0.05 was considered statistically significant. Results The genotype and allele distributions of HOTAIR polymorphisms (rs1899663, rs12826786, and rs4759314) in uterine fibroid (UF) patients and healthy controls are presented in Table 2. For the rs1899663 polymorphism, the distribution of genotypes (GG, GT, and TT) did not differ significantly between UF patients and controls. The frequencies of GG, GT, and TT genotypes were 44%, 48%, and 8% in patients compared to 47%, 44%, and 9% in controls, respectively. Similarly, no significant association was observed under any genetic model, including dominant, recessive, codominant, overdominant, or allelic models (all p > 0.05). Allele frequencies were also comparable between groups (T allele: 32% in patients vs. 31% in controls). Both groups were in Hardy–Weinberg equilibrium. In contrast, a significant association was observed for the rs12826786 polymorphism. The frequency of the TT genotype was higher in UF patients (18%) compared to controls (10%), while the CC genotype was lower in patients (27%) compared to controls (43%). The dominant model (CT + TT vs. CC) showed a significant association with increased UF risk (OR = 2.040, 95% CI = 1.127–3.691, p = 0.026). Similarly, the codominant model (TT vs. CC) was statistically significant (OR = 2.867, 95% CI = 1.153–7.126, p = 0.026). At the allelic level, the T allele frequency was significantly higher in patients (45.5%) than in controls (33.5%) (OR = 1.657, 95% CI = 1.106–2.484, p = 0.019). For the rs4759314 polymorphism, no significant differences were observed between UF patients and controls. Genotype distributions (AA, AG, and GG) and allele frequencies were comparable between groups, and no significant association was detected under any genetic model (all p > 0.05). Both groups were in Hardy–Weinberg equilibrium. Clear and specific amplification bands corresponding to expected fragment sizes (126 bp for rs1899663, 364 bp for rs12826786, and 207 bp for rs4759314) were observed. The banding patterns allowed accurate discrimination between homozygous and heterozygous genotypes. Minor non-specific bands were observed in some lanes but did not interfere with genotype interpretation, confirming the reliability of the genotyping method.Table 2Genotype and allele distribution of HOTAIR polymorphisms in healthy controls and UF patients.HOTAIR (rs 1,899,663)Healthy controls (n = 100)UF patients (n = 100)Genotypesn (N %)n (N %)GGGTTTAllele GAllele T47 (47%)44 (44%)9 (9%)138 (69.0%)62 (31.0%)44 (44%)48 (48%)8 (8%)136 (68.0%)64 (32.0%)HWEχ2 = 0.081, p = 0.776χ2 = 1.060, p = 0.303StatisticsOR (95%CI)p-valueRecessive TT vs. GG + GT0.879 (0.325–2.379)1.00Dominant (T allele carriage) GT + TT vs.GG1.129 (0.647–1.970)0.77Co dominant TT vs. GG0.949 (0.336–2.679)1.00Heterozygote model GT vs. GG1.165 (0.652–2.081)0.66Over dominant GT vs. GG + TT1.175 (0.673–2.050)0.67Allele T vs. G1.047 (0.687–1.597)0.91HOTAIR (rs12826786)Healthy controls (n = 100)UF patients (n = 100)Genotypesn (N %)n (N %)CCCTTTAllele CAllele T43 (43%)47 (47%)10 (10%)133 (66.5%)67 (33.5%)27 (27%)55 (55%)18 (18%)109 (54.5%)91 (45.5%)HWEχ2 = 0.301, p = 0.58χ2 = 1.188, p = 0.28StatisticsOR (95%CI)p-valueRecessive TT vs. CC + CT1.976 (0.862–4.526)0.15Dominant (T allele carriage) CT + TT vs. CC2.040 (1.127–3.691)0.026*Co dominant TT vs. CC2.867 (1.153–7.126)0.026*Heterozygote model CT vs. CC1.864 (1.004–3.461)0.06Over dominant CT vs. CC + TT1.378 (0.790–2.404)0.32Allele T vs. C1.657 (1.106–2.484)0.019*HOTAIR (rs4759314)Healthy controls (n = 100)UF patients (n = 100)Genotypesn (N %)n (N %)AAAGGGAllele AAllele G83 (83%)15 (15%)2 (2%)181 (90.5%)19 (9.5%)80 (80%)19 (19%)1 (1%)179 (89.5%)21 (10.5%)HWEχ2 = 0.060, p = 0.807χ2 = 0.012, p = 0.913StatisticsOR (95%CI)p-valueRecessive GG vs. AA + AG0.495 (0.045–5.447)0.56Dominant (G allele carriage) AG + GG vs.AA1.221 (0.603–2.471)0.61Co dominant GG vs. AA0.519 (0.046–5.858)0.56Heterozygote model AG vs. AA1.314 (0.620–2.787)0.46Over dominant AG vs. AA+GG1.329 (0.629–2.806)0.44Allele G vs. A1.118 (0.589–2.122)0.74 Table 2Genotype and allele distribution of HOTAIR polymorphisms in healthy controls and UF patients.HOTAIR (rs 1,899,663)Healthy controls (n = 100)UF patients (n = 100)Genotypesn (N %)n (N %)GGGTTTAllele GAllele T47 (47%)44 (44%)9 (9%)138 (69.0%)62 (31.0%)44 (44%)48 (48%)8 (8%)136 (68.0%)64 (32.0%)HWEχ2 = 0.081, p = 0.776χ2 = 1.060, p = 0.303StatisticsOR (95%CI)p-valueRecessive TT vs. GG + GT0.879 (0.325–2.379)1.00Dominant (T allele carriage) GT + TT vs.GG1.129 (0.647–1.970)0.77Co dominant TT vs. GG0.949 (0.336–2.679)1.00Heterozygote model GT vs. GG1.165 (0.652–2.081)0.66Over dominant GT vs. GG + TT1.175 (0.673–2.050)0.67Allele T vs. G1.047 (0.687–1.597)0.91HOTAIR (rs12826786)Healthy controls (n = 100)UF patients (n = 100)Genotypesn (N %)n (N %)CCCTTTAllele CAllele T43 (43%)47 (47%)10 (10%)133 (66.5%)67 (33.5%)27 (27%)55 (55%)18 (18%)109 (54.5%)91 (45.5%)HWEχ2 = 0.301, p = 0.58χ2 = 1.188, p = 0.28StatisticsOR (95%CI)p-valueRecessive TT vs. CC + CT1.976 (0.862–4.526)0.15Dominant (T allele carriage) CT + TT vs. CC2.040 (1.127–3.691)0.026*Co dominant TT vs. CC2.867 (1.153–7.126)0.026*Heterozygote model CT vs. CC1.864 (1.004–3.461)0.06Over dominant CT vs. CC + TT1.378 (0.790–2.404)0.32Allele T vs. C1.657 (1.106–2.484)0.019*HOTAIR (rs4759314)Healthy controls (n = 100)UF patients (n = 100)Genotypesn (N %)n (N %)AAAGGGAllele AAllele G83 (83%)15 (15%)2 (2%)181 (90.5%)19 (9.5%)80 (80%)19 (19%)1 (1%)179 (89.5%)21 (10.5%)HWEχ2 = 0.060, p = 0.807χ2 = 0.012, p = 0.913StatisticsOR (95%CI)p-valueRecessive GG vs. AA + AG0.495 (0.045–5.447)0.56Dominant (G allele carriage) AG + GG vs.AA1.221 (0.603–2.471)0.61Co dominant GG vs. AA0.519 (0.046–5.858)0.56Heterozygote model AG vs. AA1.314 (0.620–2.787)0.46Over dominant AG vs. AA+GG1.329 (0.629–2.806)0.44Allele G vs. A1.118 (0.589–2.122)0.74 Genotype and allele distribution of HOTAIR polymorphisms in healthy controls and UF patients. The comparison of biochemical and hormonal parameters between UF patients and controls is summarized in Table 3. UF patients exhibited significantly elevated levels of inflammatory cytokines, including IL-1β, IL-10, TNF-α, and IFN-γ (p < 0.001 for all comparisons). Hormonal analysis revealed significantly higher levels of prolactin and estradiol in UF patients compared to controls (p < 0.0001). Similarly, liver enzyme activities (ALT, AST, and ACP) were significantly increased in UF patients (p < 0.0001), indicating altered metabolic status. In contrast, total protein and albumin levels were significantly decreased in UF patients compared to controls (p < 0.0001).Table 3Statistical analysis of biochemical and hormonal parameters in uterine fibroid patients and healthy controls.ParameternControl mean ± SEMUF Patients mean ± SEMp-valueIL-1β (pg/ml)8520.28 ± 0.7538.09 ± 0.92<0.001***IL-10 (pg/ml)8530.25 ± 0.7545.82 ± 0.89<0.001***TNF-α (pg/ml)8512.00 ± 0.3343.62 ± 1.10<0.0001IFN-γ (pg/ml)8519.79 ± 0.6839.67 ± 1.35<0.0001Prolactin (ng/ml)8514.48 ± 0.4028.87 ± 0.65<0.0001Estradiol (pg/ml)8578.44 ± 2.60150.01 ± 4.31<0.0001ALT (U/L)10021.88 ± 0.5434.14 ± 0.63<0.0001AST (U/L)10020.38 ± 0.4830.03 ± 0.52<0.0001ACP (U/L)1004.83 ± 0.1412.61 ± 0.26<0.0001Total Protein (g/dl)1007.07 ± 0.046.48 ± 0.04<0.0001Albumin (g/dl)1004.32 ± 0.033.88 ± 0.03<0.0001 Table 3Statistical analysis of biochemical and hormonal parameters in uterine fibroid patients and healthy controls.ParameternControl mean ± SEMUF Patients mean ± SEMp-valueIL-1β (pg/ml)8520.28 ± 0.7538.09 ± 0.92<0.001***IL-10 (pg/ml)8530.25 ± 0.7545.82 ± 0.89<0.001***TNF-α (pg/ml)8512.00 ± 0.3343.62 ± 1.10<0.0001IFN-γ (pg/ml)8519.79 ± 0.6839.67 ± 1.35<0.0001Prolactin (ng/ml)8514.48 ± 0.4028.87 ± 0.65<0.0001Estradiol (pg/ml)8578.44 ± 2.60150.01 ± 4.31<0.0001ALT (U/L)10021.88 ± 0.5434.14 ± 0.63<0.0001AST (U/L)10020.38 ± 0.4830.03 ± 0.52<0.0001ACP (U/L)1004.83 ± 0.1412.61 ± 0.26<0.0001Total Protein (g/dl)1007.07 ± 0.046.48 ± 0.04<0.0001Albumin (g/dl)1004.32 ± 0.033.88 ± 0.03<0.0001 Statistical analysis of biochemical and hormonal parameters in uterine fibroid patients and healthy controls. The relationship between HOTAIR polymorphisms and biochemical markers in UF patients is presented in Table 4. For rs1899663, no significant differences were observed in cytokine, hormonal, or biochemical parameters between genotype groups (GG vs. GT + TT), indicating no genotype-dependent effect. Similarly, rs4759314 polymorphism showed no significant association with any of the measured biochemical or hormonal parameters. However, for rs12826786, a significant difference was observed in ALT levels, where individuals carrying the CC genotype exhibited higher ALT levels compared to CT + TT carriers (p = 0.038). No significant differences were detected for other parameters.Table 4The association of serum biochemical markers of cases of UF regarding HOTAIR.Biochemical markersrs1899663 (GG) nmean ± SErs1899663 (GT + TT) nmean ± SEp- valueIL-1β (pg/ml)3837.89 ± 1.344738.25 ± 1.280.85IL-10 (pg/ml)3844.97 ± 1.234746.51 ± 1.270.39TNF-α (pg/ml)3845.51 ± 1.734742.10 ± 1.400.12IFN-γ (pg/ml)3837.12 ± 1.964741.73 ± 1.820.09Prolactin (ng/ml)3828.30 ± 0.934729.33 ± 0.900.43Estradiol (pg/ml)38148.03 ± 6.1847151.61 ± 6.020.68ALT (U/L)4434.58 ± 0.905633.80 ± 0.880.54AST (U/L)4429.20 ± 0.765630.68 ± 0.700.15ACP (U/L)4412.35 ± 0.365612.80 ± 0.370.38Total protein (g/dl)446.42 ± 0.05566.53 ± 0.060.15Albumin (g/dl)443.82 ± 0.06563.92 ± 0.040.14Biochemical markersrs12826786 (CC) nmean ± SErs12826786 (CT + TT) nmean ± SEp- valueIL-1β (pg/ml)2537.94 ± 2.046038.15 ± 1.000.92IL-10 (pg/ml)2546.16 ± 1.346045.68 ± 1.140.81TNF-α (pg/ml)2544.35 ± 1.706043.32 ± 1.400.67IFN-γ (pg/ml)2542.66 ± 2.866038.42 ± 1.480.15Prolactin (ng/ml)2527.61 ± 1.216029.39 ± 0.760.21Estradiol (pg/ml)25149.98 ± 6.1660150.02 ± 5.570.99ALT (U/L)2736.14 ± 1.047333.41 ± 0.760.038*AST (U/L)2731.04 ± 0.907329.66 ± 0.630.21ACP (U/L)2712.41 ± 0.497312.68 ± 0.310.66Total protein (g/dl)276.44 ± 0.07736.49 ± 0.050.56Albumin (g/dl)273.90 ± 0.07733.87 ± 0.040.71Biochemical markersrs4759314 (AA)nmean ± SErs4759314 (AG + GG) nmean ± SEp- valueIL-1β (pg/ml)7338.51 ± 0.951235.51 ± 3.100.37IL-10 (pg/ml)7345.91 ± 0.951245.33 ± 2.680.84TNF-α (pg/ml)7343.23 ± 1.181246.00 ± 3.190.43IFN-γ (pg/ml)7339.57 ± 1.501240.26 ± 2.980.84Prolactin (ng/ml)7328.66 ± 0.721230.12 ± 1.480.39Estradiol (pg/ml)73148.51 ± 4.4712159.11 ± 14.090.49ALT (U/L)8034.53 ± 0.682032.59 ± 1.580.27AST (U/L)8030.44 ± 0.582028.39 ± 1.130.12ACP (U/L)8012.75 ± 0.302012.03 ± 0.530.24Total protein (g/dl)806.45 ± 0.04206.60 ± 0.100.15Albumin (g/dl)803.86 ± 0.04203.96 ± 0.070.21Values represent, n (number of cases), (N %) percentage (%) of frequencies of the genotypes, P = probability, *P < 0.05 = significant **P < 0.001 = highly significant OR = Odds ratio and CI (confidence interval). Table 4The association of serum biochemical markers of cases of UF regarding HOTAIR.Biochemical markersrs1899663 (GG) nmean ± SErs1899663 (GT + TT) nmean ± SEp- valueIL-1β (pg/ml)3837.89 ± 1.344738.25 ± 1.280.85IL-10 (pg/ml)3844.97 ± 1.234746.51 ± 1.270.39TNF-α (pg/ml)3845.51 ± 1.734742.10 ± 1.400.12IFN-γ (pg/ml)3837.12 ± 1.964741.73 ± 1.820.09Prolactin (ng/ml)3828.30 ± 0.934729.33 ± 0.900.43Estradiol (pg/ml)38148.03 ± 6.1847151.61 ± 6.020.68ALT (U/L)4434.58 ± 0.905633.80 ± 0.880.54AST (U/L)4429.20 ± 0.765630.68 ± 0.700.15ACP (U/L)4412.35 ± 0.365612.80 ± 0.370.38Total protein (g/dl)446.42 ± 0.05566.53 ± 0.060.15Albumin (g/dl)443.82 ± 0.06563.92 ± 0.040.14Biochemical markersrs12826786 (CC) nmean ± SErs12826786 (CT + TT) nmean ± SEp- valueIL-1β (pg/ml)2537.94 ± 2.046038.15 ± 1.000.92IL-10 (pg/ml)2546.16 ± 1.346045.68 ± 1.140.81TNF-α (pg/ml)2544.35 ± 1.706043.32 ± 1.400.67IFN-γ (pg/ml)2542.66 ± 2.866038.42 ± 1.480.15Prolactin (ng/ml)2527.61 ± 1.216029.39 ± 0.760.21Estradiol (pg/ml)25149.98 ± 6.1660150.02 ± 5.570.99ALT (U/L)2736.14 ± 1.047333.41 ± 0.760.038*AST (U/L)2731.04 ± 0.907329.66 ± 0.630.21ACP (U/L)2712.41 ± 0.497312.68 ± 0.310.66Total protein (g/dl)276.44 ± 0.07736.49 ± 0.050.56Albumin (g/dl)273.90 ± 0.07733.87 ± 0.040.71Biochemical markersrs4759314 (AA)nmean ± SErs4759314 (AG + GG) nmean ± SEp- valueIL-1β (pg/ml)7338.51 ± 0.951235.51 ± 3.100.37IL-10 (pg/ml)7345.91 ± 0.951245.33 ± 2.680.84TNF-α (pg/ml)7343.23 ± 1.181246.00 ± 3.190.43IFN-γ (pg/ml)7339.57 ± 1.501240.26 ± 2.980.84Prolactin (ng/ml)7328.66 ± 0.721230.12 ± 1.480.39Estradiol (pg/ml)73148.51 ± 4.4712159.11 ± 14.090.49ALT (U/L)8034.53 ± 0.682032.59 ± 1.580.27AST (U/L)8030.44 ± 0.582028.39 ± 1.130.12ACP (U/L)8012.75 ± 0.302012.03 ± 0.530.24Total protein (g/dl)806.45 ± 0.04206.60 ± 0.100.15Albumin (g/dl)803.86 ± 0.04203.96 ± 0.070.21Values represent, n (number of cases), (N %) percentage (%) of frequencies of the genotypes, P = probability, *P < 0.05 = significant **P < 0.001 = highly significant OR = Odds ratio and CI (confidence interval). The association of serum biochemical markers of cases of UF regarding HOTAIR. Values represent, n (number of cases), (N %) percentage (%) of frequencies of the genotypes, P = probability, *P < 0.05 = significant **P < 0.001 = highly significant OR = Odds ratio and CI (confidence interval). Principal component analysis (PCA) was performed to evaluate the multivariate relationships between biochemical, hormonal, and inflammatory parameters across HOTAIR genotypes in Fig. 1. The PCA biplots demonstrated distinct clustering patterns among genotypes for rs1899663, rs12826786, and rs4759314 polymorphisms. The first two principal components (PC1 and PC2) explained the majority of the variance, with cytokines, hormonal markers, and liver enzymes contributing strongly to the observed separation. Loading vectors indicated that inflammatory markers (IL-1β, TNF-α, IFN-γ) and hormonal parameters (prolactin and estradiol) were key contributors to sample distribution. Although partial overlap between genotype groups was observed, the overall clustering patterns suggest potential genotype-related variation in biochemical and inflammatory profiles.Fig. 1Principal component analysis (PCA) of biochemical and hormonal parameters in relation to HOTAIR gene polymorphisms in uterine fibroid (UF) patients. (A) Principal component analysis (PCA) biplot of biochemical and cytokine biomarkers stratified by HOTAIR rs1899663 genotypes. Each point represents an individual sample and is grouped according to genotype (GG, GT, and TT). The biplot illustrates the distribution of samples and the contribution of measured variables, including IL-1β, IL-10, TNF-α, IFN-γ, prolactin, estradiol, ALT, AST, ACP, total protein, and albumin. Arrows indicate loading vectors, reflecting the direction and magnitude of each variable's contribution to the principal components. The first two principal components (PC1 and PC2) explain the majority of the total variance, highlighting clustering patterns and relationships among inflammatory, hormonal, and biochemical markers across genotypes. (B) Principal component analysis (PCA) biplot of biochemical and hormonal parameters in relation to HOTAIR rs12826786 polymorphism. Samples are distributed according to genotypes (CC, CT, and TT) along PC1 and PC2. Loading vectors represent the contribution of cytokines, hormonal, and biochemical markers to the principal components, illustrating multivariate relationships between genotype and biomarker profiles. (C) Principal component analysis (PCA) biplot of biochemical and hormonal parameters stratified by HOTAIR rs4759314 genotypes. Each point corresponds to an individual sample categorized by genotype (AA, AG, and GG). The arrows represent variable loadings, indicating the contribution and correlation of each biomarker with the principal components. The spatial distribution of samples reflects clustering patterns and potential genotype-dependent variation in biochemical and inflammatory markers.Fig. 1 Principal component analysis (PCA) of biochemical and hormonal parameters in relation to HOTAIR gene polymorphisms in uterine fibroid (UF) patients. (A) Principal component analysis (PCA) biplot of biochemical and cytokine biomarkers stratified by HOTAIR rs1899663 genotypes. Each point represents an individual sample and is grouped according to genotype (GG, GT, and TT). The biplot illustrates the distribution of samples and the contribution of measured variables, including IL-1β, IL-10, TNF-α, IFN-γ, prolactin, estradiol, ALT, AST, ACP, total protein, and albumin. Arrows indicate loading vectors, reflecting the direction and magnitude of each variable's contribution to the principal components. The first two principal components (PC1 and PC2) explain the majority of the total variance, highlighting clustering patterns and relationships among inflammatory, hormonal, and biochemical markers across genotypes. (B) Principal component analysis (PCA) biplot of biochemical and hormonal parameters in relation to HOTAIR rs12826786 polymorphism. Samples are distributed according to genotypes (CC, CT, and TT) along PC1 and PC2. Loading vectors represent the contribution of cytokines, hormonal, and biochemical markers to the principal components, illustrating multivariate relationships between genotype and biomarker profiles. (C) Principal component analysis (PCA) biplot of biochemical and hormonal parameters stratified by HOTAIR rs4759314 genotypes. Each point corresponds to an individual sample categorized by genotype (AA, AG, and GG). The arrows represent variable loadings, indicating the contribution and correlation of each biomarker with the principal components. The spatial distribution of samples reflects clustering patterns and potential genotype-dependent variation in biochemical and inflammatory markers. Values represent, n (number of cases), (N %) percentage (%) of frequencies of the genotypes, P = probability, *p < 0.05 = significant **p < 0.001 = highly significant OR = Odds ratio and CI (confidence interval), HWE, Hardy –Weinberg equilibrium. Data are expressed as mean ± SEM. *p < 0.05 significant; **p < 0.01 highly significant; ***p < 0.001 extremely significant; ns: non-significant. IL-1β, interleukin-1 beta; IL-10, interleukin-10; TNF-α, tumor necrosis factor-alpha; IFN-γ, interferon-gamma; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ACP, acid phosphatase; TP, total protein; ALB, albumin; SEM, standard error of the mean. Discussion Uterine fibroids (UFs) represent a highly prevalent benign gynecological disorder characterized by complex interactions among genetic, hormonal, and inflammatory factors.3, 4, 16 In the present study, we evaluated the association between HOTAIR gene polymorphisms (rs1899663, rs12826786, and rs4759314) and UF susceptibility in Egyptian women, in parallel with their relationship to inflammatory cytokines, hormonal profiles, and biochemical parameters. Our findings identify rs12826786 as a significant genetic determinant of UF risk, while rs1899663 and rs4759314 did not demonstrate a significant association. Furthermore, marked dysregulation of inflammatory, endocrine, and metabolic markers observed in UF patients underscores the systemic nature of the disease. The most compelling observation in this study is the significant association between the rs12826786 polymorphism and increased UF susceptibility, particularly the enrichment of the T allele and TT genotype among affected individuals. This finding suggests that rs12826786 may represent a genetic susceptibility marker for uterine fibroids. However, no functional or in silico analyses were performed in the present study to evaluate the potential impact of this variant on HOTAIR expression, RNA structure, or regulatory activity. Therefore, the biological mechanism underlying this association remains unclear, and the observed association should be interpreted as a statistical relationship rather than evidence of direct functional causality. Further experimental and computational studies are warranted to clarify the functional significance of rs12826786HOTAIR also functions as an epigenetic regulator that modulates chromatin accessibility and gene expression through PRC2 and LSD1 recruitment, thereby influencing fibrotic and proliferative pathways relevant to uterine fibroid development.13 Genetic variations within HOTAIR may alter its transcriptional efficiency or structural conformation, leading to aberrant gene regulation and increased susceptibility to proliferative disorders.7, 19, 20 Our findings are consistent with prior studies reporting a risk-enhancing effect of rs12826786 in tumor-related conditions, including uterine leiomyoma and various cancers.15, 21 Moreover, recent meta-analyses have confirmed that HOTAIR polymorphisms, particularly rs12826786, are associated with increased cancer susceptibility across multiple populations.21, 22 These observations collectively support the hypothesis that rs12826786 may function as a regulatory variant influencing HOTAIR-mediated epigenetic pathways relevant to fibroid development. In contrast, the absence of significant associations for rs1899663 and rs4759314 in our cohort suggests SNP-specific functional heterogeneity within the HOTAIR gene. This is in agreement with several recent studies indicating that not all HOTAIR polymorphisms exert equivalent biological effects, and their contribution to disease risk may vary depending on genomic context and population genetics.23, 24, 25, 26 Additionally, ethnic variability and gene–environment interactions may further modulate the penetrance of these variants, highlighting the importance of conducting population-specific genetic investigations. The biological relevance of HOTAIR in UF pathogenesis is further supported by its established role in epigenetic reprogramming and fibrosis-related pathways. Aberrant HOTAIR expression has been linked to enhanced cellular proliferation, extracellular matrix (ECM) accumulation, and resistance to apoptosis, all of which are hallmark features of uterine fibroids. Mechanistically, HOTAIR regulates genes involved in TGF-β signaling, a central pathway in fibrogenesis.27 Therefore, genetic alterations affecting HOTAIR function may contribute to fibroid formation through dysregulated epigenetic control of profibrotic genes. In addition to genetic associations, our study revealed significant elevation of inflammatory cytokines (IL-1β, IL-10, TNF-α, and IFN-γ) in UF patients, reinforcing the concept that chronic inflammation is a key driver of fibroid development. Pro-inflammatory cytokines promote ECM deposition and cellular proliferation through activation of NF-κB and TGF-β signaling pathways, thereby contributing to fibrotic remodeling.16 Recent studies have further demonstrated that inflammatory signaling can interact with epigenetic regulators, including lncRNAs,7, 19 suggesting a potential mechanistic link between HOTAIR variants and cytokine dysregulation. Hormonal analysis in our study demonstrated significantly elevated estradiol and prolactin levels in UF patients, which is consistent with the well-established role of endocrine factors in fibroid growth. Estrogen promotes smooth muscle cell proliferation and ECM production, while prolactin may enhance fibrotic signaling and angiogenesis.4, 28 Importantly, recent evidence indicates that estrogen signaling can directly regulate lncRNA expression, including HOTAIR, thereby linking hormonal and epigenetic pathways in tumorigenesis.29 Our biochemical findings, including elevated liver enzymes (ALT, AST, ACP) and reduced total protein and albumin levels, suggest systemic metabolic alterations associated with UF. These changes may reflect oxidative stress and chronic inflammatory burden, which have been increasingly recognized as contributors to fibroid pathophysiology.16 Notably, the observed association between rs12826786 and ALT levels provides preliminary evidence that HOTAIR polymorphisms may influence metabolic pathways, although further validation is required. Multivariate analysis using PCA revealed that inflammatory and hormonal markers are major contributors to the variance observed in UF patients, highlighting the integrated nature of these biological systems. Although genotype-specific clustering was not entirely distinct, the observed trends suggest that genetic variation may modulate the overall biochemical phenotype. This integrative approach provides a more comprehensive understanding of the interplay between genetic and systemic factors in UF. Despite the strengths of this study, several limitations should be acknowledged. The relatively modest sample size may limit the statistical power to detect weaker associations. Additionally, functional validation of the identified polymorphisms was not performed, and therefore mechanistic conclusions remain speculative. Furthermore, environmental and lifestyle factors were not extensively evaluated, which may influence disease susceptibility. Future research should focus on large-scale, multi-ethnic studies combined with functional assays to elucidate the molecular mechanisms underlying HOTAIR-mediated regulation. Integration of genomic, transcriptomic, and epigenetic data will be essential to identify novel biomarkers and therapeutic targets for uterine fibroids. Conclusions In summary, the present study provides novel evidence supporting the role of HOTAIR gene polymorphisms in the pathogenesis of uterine fibroids among Egyptian women. Specifically, the rs12826786 variant was significantly associated with increased susceptibility to uterine fibroids, highlighting its potential as a genetic risk factor. In contrast, rs1899663 and rs4759314 polymorphisms did not demonstrate a significant contribution, suggesting variant-specific effects within the HOTAIR locus. Beyond genetic associations, uterine fibroid patients exhibited marked alterations in inflammatory cytokines, hormonal profiles, and biochemical parameters, reflecting the complex and systemic nature of the disease. The observed elevation of pro-inflammatory cytokines and hormonal markers, together with metabolic disturbances, underscores the interplay between inflammation, endocrine signaling, and genetic regulation in fibroid development. Notably, the association between rs12826786 and ALT levels suggests a potential link between HOTAIR genetic variation and metabolic pathways. These findings collectively support the hypothesis that HOTAIR-mediated epigenetic regulation contributes to uterine fibroid susceptibility through integrated inflammatory and hormonal mechanisms. From a clinical perspective, HOTAIR polymorphisms particularly rs12826786 may serve as promising biomarkers for identifying individuals at increased risk of uterine fibroids and may provide a foundation for personalized diagnostic and therapeutic strategies. However, further studies involving larger, multi-ethnic populations and functional investigations are warranted to validate these findings and to elucidate the underlying molecular mechanisms. Integration of genomic, transcriptomic, and epigenetic approaches will be essential to fully characterize the role of long non-coding RNAs in uterine fibroid pathophysiology and to explore their potential as therapeutic targets. The following are the supplementary data related to this article.Supplementary Fig. S1Agarose gel electrophoresis of ARMS-PCR products for the HOTAIR (rs1899663) polymorphism. Each pair of lanes corresponds to one participant. M: 100-bp DNA ladder. A specific 126 bp amplification fragment is observed. Lanes L1–L2 and L9–L10 indicate the GT heterozygous genotype; lanes L5–L6 indicate the TT homozygous genotype; and lanes L7–L8 and L11–L12 indicate the GG homozygous genotype. Lanes L3–L4 show minor non-specific bands that did not interfere with genotype interpretation.Supplementary Fig. S2Agarose gel electrophoresis of ARMS-PCR products for the HOTAIR (rs12826786) polymorphism. Each pair of lanes corresponds to one participant. M: 100-bp DNA ladder. A specific 364 bp amplification fragment is observed. Lanes L1–L2 indicate the TT homozygous genotype; lanes L3–L4, L5–L6, L7–L8, L9–L10, L11–L12, L17–L18, L19–L20, L21–L22, and L23–L24 indicate the CT heterozygous genotype; and lanes L13–L14 indicate the CC homozygous genotype. Lanes L15–L16 show minor non-specific bands that did not interfere with genotype interpretation.Supplementary Fig. S3Agarose gel electrophoresis of ARMS-PCR products for the HOTAIR (rs4759314) polymorphism. Each pair of lanes corresponds to one participant. M: 100-bp DNA ladder. A specific 207 bp amplification fragment is observed. Lanes L1–L2, L3–L4, L5–L6, and L7–L8 indicate the AG heterozygous genotype; lanes L9–L10 indicate the AA homozygous genotype; and lanes L11–L12 indicate the GG homozygous genotype.Supplementary Fig. S4Genotypic and allelic frequency distribution of HOTAIR polymorphisms in uterine fibroid (UF) patients and healthy controls. (A) Genotype and allele frequencies of HOTAIR rs1899663 in uterine fibroid patients and healthy controls. Data are expressed as percentage frequencies of each genotype (GG, GT, and TT) and allele (G and T) within each group. Blue bars represent healthy controls, while red bars represent uterine fibroid patients. (B) Comparison of allele frequencies of HOTAIR rs1899663 between uterine fibroid patients (Egyptian population) and global populations from the 1000 Genomes Project. The bar chart illustrates the percentage distribution of G and T alleles in the present study compared with African (AFR), American (AMR), East Asian (EAS), European (EUR), and South Asian (SAS) populations. (C) Genotype and allele frequencies of HOTAIR rs12826786 in uterine fibroid patients and healthy controls. Data are expressed as percentage frequencies of each genotype (CC, CT, and TT) and allele (C and T) within each group. (D) Comparison of allele frequencies of HOTAIR rs12826786 between uterine fibroid patients (Egyptian population) and global populations from the 1000 Genomes Project (AFR, AMR, EAS, EUR, and SAS). (E) Genotype and allele frequencies of HOTAIR rs4759314 in uterine fibroid patients and healthy controls. Data are expressed as percentage frequencies of each genotype (AA, AG, and GG) and allele (A and G) within each group. (F) Comparison of allele frequencies of HOTAIR rs4759314 between uterine fibroid patients (Egyptian population) and global populations from the 1000 Genomes Project (AFR, AMR, EAS, EUR, and SAS).Supplementary Fig. S5Schematic representation of the genomic locations of the HOTAIR polymorphisms rs1899663, rs12826786, and rs4759314. Panels (A–C) show the locations of rs1899663, rs12826786, and rs4759314, respectively, within the HOTAIR locus on chromosome 12q13.13. Panels (D–F) illustrate the relative positions of these variants within the functional regions of HOTAIR, including the 5′ PRC2-binding region, core region, and 3′ LSD1-binding region.Supplementary Fig. S6Spearman correlation matrix showing the relationships among biochemical, inflammatory, and hormonal parameters . Positive correlations are shown in red and negative correlations in blue, with the values representing Spearman’s correlation coefficients (r). Agarose gel electrophoresis of ARMS-PCR products for the HOTAIR (rs1899663) polymorphism. Each pair of lanes corresponds to one participant. M: 100-bp DNA ladder. A specific 126 bp amplification fragment is observed. Lanes L1–L2 and L9–L10 indicate the GT heterozygous genotype; lanes L5–L6 indicate the TT homozygous genotype; and lanes L7–L8 and L11–L12 indicate the GG homozygous genotype. Lanes L3–L4 show minor non-specific bands that did not interfere with genotype interpretation. Agarose gel electrophoresis of ARMS-PCR products for the HOTAIR (rs12826786) polymorphism. Each pair of lanes corresponds to one participant. M: 100-bp DNA ladder. A specific 364 bp amplification fragment is observed. Lanes L1–L2 indicate the TT homozygous genotype; lanes L3–L4, L5–L6, L7–L8, L9–L10, L11–L12, L17–L18, L19–L20, L21–L22, and L23–L24 indicate the CT heterozygous genotype; and lanes L13–L14 indicate the CC homozygous genotype. Lanes L15–L16 show minor non-specific bands that did not interfere with genotype interpretation. Agarose gel electrophoresis of ARMS-PCR products for the HOTAIR (rs4759314) polymorphism. Each pair of lanes corresponds to one participant. M: 100-bp DNA ladder. A specific 207 bp amplification fragment is observed. Lanes L1–L2, L3–L4, L5–L6, and L7–L8 indicate the AG heterozygous genotype; lanes L9–L10 indicate the AA homozygous genotype; and lanes L11–L12 indicate the GG homozygous genotype. Genotypic and allelic frequency distribution of HOTAIR polymorphisms in uterine fibroid (UF) patients and healthy controls. (A) Genotype and allele frequencies of HOTAIR rs1899663 in uterine fibroid patients and healthy controls. Data are expressed as percentage frequencies of each genotype (GG, GT, and TT) and allele (G and T) within each group. Blue bars represent healthy controls, while red bars represent uterine fibroid patients. (B) Comparison of allele frequencies of HOTAIR rs1899663 between uterine fibroid patients (Egyptian population) and global populations from the 1000 Genomes Project. The bar chart illustrates the percentage distribution of G and T alleles in the present study compared with African (AFR), American (AMR), East Asian (EAS), European (EUR), and South Asian (SAS) populations. (C) Genotype and allele frequencies of HOTAIR rs12826786 in uterine fibroid patients and healthy controls. Data are expressed as percentage frequencies of each genotype (CC, CT, and TT) and allele (C and T) within each group. (D) Comparison of allele frequencies of HOTAIR rs12826786 between uterine fibroid patients (Egyptian population) and global populations from the 1000 Genomes Project (AFR, AMR, EAS, EUR, and SAS). (E) Genotype and allele frequencies of HOTAIR rs4759314 in uterine fibroid patients and healthy controls. Data are expressed as percentage frequencies of each genotype (AA, AG, and GG) and allele (A and G) within each group. (F) Comparison of allele frequencies of HOTAIR rs4759314 between uterine fibroid patients (Egyptian population) and global populations from the 1000 Genomes Project (AFR, AMR, EAS, EUR, and SAS). Schematic representation of the genomic locations of the HOTAIR polymorphisms rs1899663, rs12826786, and rs4759314. Panels (A–C) show the locations of rs1899663, rs12826786, and rs4759314, respectively, within the HOTAIR locus on chromosome 12q13.13. Panels (D–F) illustrate the relative positions of these variants within the functional regions of HOTAIR, including the 5′ PRC2-binding region, core region, and 3′ LSD1-binding region. Spearman correlation matrix showing the relationships among biochemical, inflammatory, and hormonal parameters . Positive correlations are shown in red and negative correlations in blue, with the values representing Spearman’s correlation coefficients (r). Studies in human This study was performed in compliance with relevant laws, regulatory frameworks and guidelines where the research took place. This study was approved by the Faculty of Medicine, Mansoura University. (Approval No. Sci-Ch-ph -2021-136) Author contribution All authors contributed to all parts of the research, including study design, methodology, data collection, data analysis, interpretation of results, manuscript drafting, and critical revision. All authors read and approved the final version of the manuscript. CRediT authorship contribution statement Mona M. Gad: Writing – review & editing, Writing – original draft, Visualization, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Hossam Abdel-Megeed Abdou: Writing – review & editing. Magdy M. Youssef: Writing – review & editing, Validation, Supervision. Consent to participate Informed written consent was obtained from all individual participants included in the study. Consent to publish No identifying information of participants was published. Consent for publication is not applicable. Informed consent and patient details Written informed consent to take part in the study and to publish the article has been obtained from all participants or their legal representatives. The privacy rights of participants have been observed. Ethics approval This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Faculty of Medicine, Mansoura University (Approval No. Sci-Ch-ph -2021-136; Date: 04/10/2021). Funding The authors did not receive support from any organization for the submitted work. No funding was received to assist with the preparation of this manuscript. The authors have no relevant financial or non-financial interests to disclose. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.